9:00 AM - 9:12 AM

[26X-am01] Distribution in the spinal cord and therapeutic effects for amyotrophic lateral sclerosis of hydrophilic drug by intranasal administration combined with cell-penetrating peptide-modified polymer micelles

○Takanori Kanazawa¹, Akiko Asami¹, Yuya Nito¹, Sayaka Fukuda¹, Takashi Udagawa¹, Takumi Kurano¹, Naoto Suzuki¹, Kaname Hashizaki¹, Yasuhiro Kosuge¹, Toyofumi Suzuki¹ (1. Sch. Pharm., Nihon Univ.)

9:12 AM - 9:24 AM

[26X-am02S] Comparison of characteristics of probiotic-derived extracellular vesicles

○Maho Horita¹, Masaki Morishita¹, Hidemasa Kastumi¹, Akira Yamamoto¹ (1. Kyoto Pharm Univ.)

9:24 AM - 9:36 AM

[26X-am03S] Elucidation of the immune function of Bifidobacterium-derived extracellular vesicles for their therapeutic application

○Motoki Matsuyama¹, Masaki Morishita¹, Hidemasa Katsumi¹, Akira Yamamoto¹ (1. Kyoto Pharm. Univ.)

9:36 AM - 9:48 AM

[26X-am04S] Development of polymer ligand-modified liposomes for neutralizing target toxins

○Ikumi Yamaichi¹, Hiroyuki Koide¹, Hiroki Tsuchida¹, Yu Hoshino², Naoto Oku³, Tomohiro Asai¹ (1. Univ. Shizuoka, Sch. Pharm. Sci., 2. Dept. Chem. Eng., Kyusyu Univ., 3. Teikyo Univ., Sch. Pharm.)

9:48 AM - 10:00 AM

[26X-am05S] Development of pancreatic β-cell targeting extracellular vesicles for type 1 diabetes therapy

○Gaku Futagami¹, Kosuke Kusamori¹, Makiya Nishikawa¹ (1. Fac. Pharm. Sci., Tokyo Univ. Sci.)

10:00 AM - 10:12 AM

[26X-am06] Development of lipid nanoparticle for a delivery of nucleic acids to lymphatic endothelial cells

○Yu Sakurai¹, Nodoka Abe¹, Satoshi Ogasawara², Yukinari Kato³, Murata Takeshi², Kouta Tange⁴, Yuta Nakai⁴, Hiroki Yoshioka⁴, Shinya Tamagawa⁴, Hiroki Tanaka¹, Hidetaka Akita¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Sci., Chiba Univ., 3. Sch. Med., Tohoku Univ., 4. NOF CORP.)

10:12 AM - 10:24 AM

[26X-am07S] Design of liposomal physical properties for lymph node targeting

○Masaki Gomi¹, Yu Sakurai¹, Hiroki Tanaka¹, Hidetaka Akita¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

10:24 AM - 10:36 AM

[26X-am08S] Development of blood-brain barrier crossing peptide grafted liposomes

○Naoya Kato¹, Rino Suzuki¹, Yoshiki Iida¹, Sakura Yamada¹, Shintaro Fumoto¹, Shigeru Kawakami¹ (1. Grad. Sch. Biomed. Sci., Nagasaki Univ.)

10:36 AM - 10:48 AM

[26X-am09S] Development of muscle-specific peptide modified nano-DDS in systemic administration

○Eri Sasaki¹, Yoshihiro Hayashi², Yuuka Kimura², Kei Nirasawa¹, Nobuhito Hamamo¹, Fumihiko Katagiri¹, Tsuyoshi Miura¹, Yamato Kikkawa¹, Yoko Takahashi¹, Motoyoshi Nomizu¹, Yoichi Negishi¹ (1. Grad.Sch.Pharm. Tokyo Univ of Pharmacy and Life Sciences, 2. Tokyo Univ of Pharmacy and Life Sciences)

10:48 AM - 11:00 AM

[26X-am10] Size and charge effect of lipid nanoparticles on transitivity to lymph node and distribution in lymph node

○Takashi Nakamura¹, Minori Kawai¹, Yusuke Sato¹, Masatoshi Maeki², Manabu Tokeshi², Hideyoshi Harashima¹ (1. Fac. Pharm. Sci. Hokkaido Univ., 2. Fac. Engineer. Hokkaido Univ.)

11:00 AM - 11:12 AM

[26X-am11] Photodynamic therapy for cancer using mitochondrial drug delivery system

○Yuma Yamada¹, Satrialdi -^1,2, Yuta Takano³, Vasudevanpillai BIJU³, Hideyoshi Harashima¹ (1. Fac. Pharm. Sci., Hokkaido Univ., 2. Sch. Pharm., Inst. Tek. Bandung, 3. RIES, Hokkaido Univ.)

11:12 AM - 11:24 AM

[26X-am12S] Clarification of dissolution mechanism of indomethacin/saccharin/polyvinylpyrrolidone ternary solid dispersion

○Mami Kosaka¹, Keisuke Ueda¹, Kenjirou Higashi¹, Kunikazu Moribe¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)

11:24 AM - 11:36 AM

[26X-am13] Study of oral administration vitamin B₁₂ for intestinal absorption without intrinsic factor

○Ikumi Sugiyama¹, Nana Suzuki¹, Yasuyuki Sadzuka¹ (1. Sch. Pharm., Iwate Med. Univ.)

Session information

[26X-am] ターゲティング、その他